normal 0 false false false en-us x-none ar-sa background: obesity in accordance with metabolic syndrome (mets) confronts populations at the higher risk of morbidity and mortality of chronic diseases including, chronic kidney diseases (ckd). the renal complication of obesity and mets has been less debated in young adolescents. the objective of this study was to assess the kidney function in obes...

conclusions the lee is a common finding among kidney transplant recipients. serial monitoring of aminotransferases, particularly alt, should be performed in all patients after kidney transplantation. patients and methods liver enzymes and other biochemical parameters were measured in all recipients. patients were divided into three groups, according to laboratory test time since transplantation...

The new immunosuppressive agent, cyclosporin A, was used with low doses of steroids to treat eight patients undergoing hepatic transplantation and three patients undergoing cadaveric renal transplantation. Seven of the eight liver recipients are well, including one who was given two livers. The three kidney recipients who had developed cytotoxic antibodies after previously rejecting grafts with...

Between March 27, 1989 and December 31, 1997, 1316 kidney transplantations alone were performed under tacrolimus-based immunosuppression at our center. Posttransplant lymphoproliferative disorders (PTLD) developed in 25 (1.9%) cases; the incidence in adults was 1.20/c (1511217). whereas in pediatric patients it was 10.IO/c (10/99; P<.OOOl). PTLD was diagnosed 21.0±22.5 months after transplantat...

Tacrolimus is a superior immunosuppressive agent in patients undergoing renal transplantation. In adults, the 1- and 3-year actuarial patient survivals were 95% and 92%, and the 1- and 3-year actuarial graft survivals were 89% and 80%. For first cadaver kidneys, the 1- and 3-year actuarial graft survivals were 91% and 82%, with a projected half-life of 11.9 years. Sixty-nine percent of successf...

To determine whether steroid avoidance in pediatric kidney transplantation is safe and efficacious, a randomized, multicenter trial was performed in 12 pediatric kidney transplant centers. One hundred thirty children receiving primary kidney transplants were randomized to steroid-free (SF) or steroid-based (SB) immunosuppression, with concomitant tacrolimus, mycophenolate and standard dose dacl...